{
  "retracted": false,
  "timestamp": 1489104000000,
  "updates": [
    {
      "timestamp": 1550363381055,
      "identifier": {
        "doi": "10.1074/jbc.a117.553818"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1074/jbc.m114.553818"
  },
  "publisher": "American Society for Biochemistry & Molecular Biology (ASBMB)",
  "title": "Selectively targeting the DNA-binding domain of the androgen receptor as a prospective therapy for prostate cancer."
}
